Previous studies showed that B cells can promote differentiation of tumor-specific CD4+ T follicular helper cells in a neoantigen-dependent manner, which in turn enhanced CD8+ T cell effector function through IL-21 production and drove anti-tumor immunity in a mouse lung adenocarcinoma model (46). Here, CD8A is linked to neoplasm.